Friday 6 November 2026
Export MTD’s income statement to Excel — free account
Mettler-Toledo International, Inc.
MTD Healthcare Diagnostics & Research
Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024.
- Revenue
- +6.27%
- EPS
- +16.2%
- Free cash flow
- +33.0%
- Total debt
- −8.42%
Quarter to September 2026, against a year earlier
1,749.08
70.00
+4.17%
Follow MTD
Alert me
| Sep '26 From the 10-Q filed 6 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
9 | 8 | 6 | 5 |
+8 more TTM periods Free account |
| (1,089.06%) | (736.36%) | (781.77%) | (1,154.87%) | ||
| 25.89% | 25.61% | 25.35% | 25.00% | ||
ROIC |
0.00% | 35.40% | 33.09% | 33.91% | |
Return on Tangible Assets |
97.58% | 92.52% | 83.03% | 86.04% | |
Average Days of Receivables |
63.74 | 64.59 | 63.21 | 70.55 | |
Free Cash Flow per Share |
49.31 | 42.94 | 39.13 | 41.18 | |
Free Cash Flow |
984.37 | 863.97 | 793.83 | 848.65 | |
Capital Expenditures |
— | (111.20) | (107.28) | (107.12) | |
| Other line items | |||||
Cash ROIC |
45.71% | 39.70% | 35.32% | 38.66% | |
Accounts Receivable Turnover |
5.91 | 5.85 | 6.07 | 5.50 | |
Accounts Payable Turnover |
6.54 | 7.37 | 7.76 | 6.78 | |
Inventory Turnover |
3.95 | 4.11 | 4.37 | 4.48 | |
Average Days of Payables |
57.32 | 51.05 | 50.01 | 59.50 | |
Days of Inventory on Hand |
96.51 | 91.43 | 88.52 | 86.41 | |
Tax Rate |
(0.17) | (0.17) | (0.17) | (0.17) | |
Research and Development Expense of Revenue |
5.01% | 5.03% | 5.00% | 4.95% | |
Selling, General and Administrative Expense of Revenue |
24.98% | 24.91% | 24.79% | 24.79% | |
Share Based Compensation of Revenue |
0.55% | 0.55% | 0.56% | 0.56% | |
Interest Coverage |
0.00 | 16.94 | 16.34 | 16.32 | |
Operating CF/Net income |
1.05 | 1.08 | 1.03 | 1.10 | |
Depreciation/Fixed assets |
0.16 | 0.16 | 0.16 | 0.15 | |
Capex/Depreciation |
0.00 | (0.85) | (0.83) | (0.85) | |
Revenue per Share |
210.30 | 205.44 | 201.61 | 195.36 | |
Operating CF per Share |
49.31 | 48.46 | 44.42 | 46.37 | |
Capex per Share |
0.00 | (5.53) | (5.29) | (5.20) | |
Capex to Sales |
0.00 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 6 Nov 2026